Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1998 1
2001 1
2002 5
2003 1
2005 2
2006 4
2007 6
2008 4
2009 3
2010 3
2011 5
2013 4
2014 4
2015 5
2016 8
2017 3
2018 7
2019 7
2020 10
2021 10
2022 12
2023 13
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Symptom burden and health-related quality of life in chronic kidney disease: A global systematic review and meta-analysis.
Fletcher BR, Damery S, Aiyegbusi OL, Anderson N, Calvert M, Cockwell P, Ferguson J, Horton M, Paap MCS, Sidey-Gibbons C, Slade A, Turner N, Kyte D. Fletcher BR, et al. PLoS Med. 2022 Apr 6;19(4):e1003954. doi: 10.1371/journal.pmed.1003954. eCollection 2022 Apr. PLoS Med. 2022. PMID: 35385471 Free PMC article.

A number of symptoms were significantly (p < 0.05 after adjustment for multiple testing) less prevalent and/or less severe within the post-transplantation population, which may suggest attribution to CKD (fatigue, depression, itching, poor mobility, poor sleep, a

…

A number of symptoms were significantly (p < 0.05 after adjustment for multiple testing) less prevalent and/or less severe within the pos

…
Amisulpride Augmentation in Schizophrenia Patients with Poor Response to Olanzapine: A 4-week, Randomized, Rater-Blind, Controlled, Pilot Study.
Woo YS, Park SY, Yoon BH, Choi WS, Wang SM, Bahk WM. Woo YS, et al. Clin Psychopharmacol Neurosci. 2022 Aug 31;20(3):567-572. doi: 10.9758/cpn.2022.20.3.567. Clin Psychopharmacol Neurosci. 2022. PMID: 35879041 Free PMC article.
OBJECTIVE: The purpose of this study was to compare the efficacy and tolerability of continued olanzapine (OLA) versus amisulpride (AMI) augmentation in schizophrenic patients with poor response to OLA monotherapy. METHODS: The present 4-week, randomized, rat …
OBJECTIVE: The purpose of this study was to compare the efficacy and tolerability of continued olanzapine (OLA) versus amisulpride (A …
The Mauli Ola Study: A Unique Academic-Community Partnership With MA'O Organic Farms to Understand and Address Health Inequities Among Native Hawaiians and Other Pacific Islanders in Hawai'i.
Maunakea AK, Juarez R, Maunakea-Forth JK. Maunakea AK, et al. Health Promot Pract. 2023 Nov;24(6):1087-1090. doi: 10.1177/15248399231190356. Health Promot Pract. 2023. PMID: 37877635 Free PMC article.
The program also engages YLT interns and their social networks in health education and research in the ongoing Mauli Ola study. Preliminary data from this study affirm the need to address the disproportionately high rates of obesity, type 2 diabetes mellitus (T2D), and …
The program also engages YLT interns and their social networks in health education and research in the ongoing Mauli Ola study. Preli …
Combining Olaparib and Ascorbic Acid on Nanoparticles to Enhance the Drug Toxic Effects in Pancreatic Cancer.
Quiñonero F, Parra-Torrejón B, Ramírez-Rodríguez GB, Garcés V, Delgado-López JM, Jiménez-Luna C, Perazzoli G, Melguizo C, Prados J, Ortíz R. Quiñonero F, et al. Int J Nanomedicine. 2023 Sep 6;18:5075-5093. doi: 10.2147/IJN.S415631. eCollection 2023. Int J Nanomedicine. 2023. PMID: 37701822 Free PMC article.
In vivo studies were carried out on tumors derived from the PANC-1 line in NOD SCID gamma (NSG) mice. RESULTS: NP-ACP-OLA-AA was loaded with 13%wt of OLA (75% loading efficiency) and 1% of AA, respectively. ...Interestingly, the in vivo assays using immunosuppressed …
In vivo studies were carried out on tumors derived from the PANC-1 line in NOD SCID gamma (NSG) mice. RESULTS: NP-ACP-OLA-AA was load …
Codelivery of adavosertib and olaparib by tumor-targeting nanoparticles for augmented efficacy and reduced toxicity.
Wang W, Xiong Y, Hu X, Lu F, Qin T, Zhang L, Guo E, Yang B, Fu Y, Hu D, Fan J, Qin X, Liu C, Xiao R, Chen G, Li Z, Sun C. Wang W, et al. Acta Biomater. 2023 Feb;157:428-441. doi: 10.1016/j.actbio.2022.12.021. Epub 2022 Dec 19. Acta Biomater. 2023. PMID: 36549633 Free article.
In this work, we designed a tumor-targeting peptide TMTP1 modified MPDA-based nano-drug delivery system (TPNPs) for targeted co-delivery of Ada and Ola to treat OC. Ada and Ola could be effectively loaded into MPDA nanoplatform and showed tumor microenvironment trig …
In this work, we designed a tumor-targeting peptide TMTP1 modified MPDA-based nano-drug delivery system (TPNPs) for targeted co-delivery of …
Olaparib nanoparticles potentiated radiosensitization effects on lung cancer.
Wu M, Liu J, Hu C, Li D, Yang J, Wu Z, Yang L, Chen Y, Fu S, Wu J. Wu M, et al. Int J Nanomedicine. 2018 Dec 11;13:8461-8472. doi: 10.2147/IJN.S181546. eCollection 2018. Int J Nanomedicine. 2018. PMID: 30587971 Free PMC article.
Moreover, poor water solubility and severe toxicity are two major impediments for the clinical success of Ola. ...In addition, the sensitization enhancement ratio of Ola-NPs (3.81) was much higher than that of free Ola (1.66). The combination of Ola …
Moreover, poor water solubility and severe toxicity are two major impediments for the clinical success of Ola. ...In addition, …
Abstracts from the 3rd International Genomic Medicine Conference (3rd IGMC 2015) : Jeddah, Kingdom of Saudi Arabia. 30 November - 3 December 2015.
Shay JW, Homma N, Zhou R, Naseer MI, Chaudhary AG, Al-Qahtani M, Hirokawa N, Goudarzi M, Fornace AJ Jr, Baeesa S, Hussain D, Bangash M, Alghamdi F, Schulten HJ, Carracedo A, Khan I, Qashqari H, Madkhali N, Saka M, Saini KS, Jamal A, Al-Maghrabi J, Abuzenadah A, Chaudhary A, Al Qahtani M, Damanhouri G, Alkhatabi H, Goodeve A, Crookes L, Niksic N, Beauchamp N, Abuzenadah AM, Vaught J, Budowle B, Assidi M, Buhmeida A, Al-Maghrabi J, Buhmeida A, Assidi M, Merdad L, Kumar S, Miura S, Gomez K, Carracedo A, Rasool M, Rebai A, Karim S, Eldin HFN, Abusamra H, Alhathli EM, Salem N, Al-Qahtani MH, Kumar S, Faheem H, Agarwa A, Nieschlag E, Wistuba J, Damm OS, Beg MA, Abdel-Meguid TA, Mosli HA, Bajouh OS, Abuzenadah AM, Al-Qahtani MH, Coskun S, Abu-Elmagd M, Buhmeida A, Dallol A, Al-Maghrabi J, Hakamy S, Al-Qahtani W, Al-Harbi A, Hussain S, Assidi M, Al-Qahtani M, Abuzenadah A, Ozkosem B, DuBois R, Messaoudi SS, Dandana MT, Mahjoub T, Almawi WY, Abdalla S, Al-Aama MN, Elzawahry A, Takahashi T, Mimaki S, Furukawa E, Nakatsuka R, Kurosaka I, Nishigaki T, Nakamura H, Serada S, Naka T, Hirota S, Shibata T, Tsuchihara K, Nishida T, Kato M, Mehmood S, Ashraf NM, Asif A, Bilal M, Mehmood MS, Hussain … See abstract for full author list ➔ Shay JW, et al. BMC Genomics. 2016 Jul 20;17 Suppl 6(Suppl 6):487. doi: 10.1186/s12864-016-2858-0. BMC Genomics. 2016. PMID: 27454254 Free PMC article.
Marfatia, Rasheedunnisa Begum P23 Cytogenetics abnormalities in 12,884 referred population for chromosomal analysis and the role of FISH in refining the diagnosis (cytogenetic experience 2004-2013) Amal M Mohamed, Alaa K Kamel, Nivin A Helmy, Sayda A Hammad, Hesham F Kayed, Marwa …
Marfatia, Rasheedunnisa Begum P23 Cytogenetics abnormalities in 12,884 referred population for chromosomal analysis and the role of FISH in …
PARP1 inhibition by Olaparib reduces the lethality of pancreatic cancer cells and increases their sensitivity to Gemcitabine.
Quiñonero F, Mesas C, Muñoz-Gámez JA, Jiménez-Luna C, Perazzoli G, Prados J, Melguizo C, Ortiz R. Quiñonero F, et al. Biomed Pharmacother. 2022 Nov;155:113669. doi: 10.1016/j.biopha.2022.113669. Epub 2022 Sep 13. Biomed Pharmacother. 2022. PMID: 36113257 Free article.
To determine the relevance of PARP1 in the development and treatment of PC, we used the Panc02 cell line to generate modified PC cells with stably inhibited PARP1 expression (Panc02-L) and used GMZ, Olaparib (OLA) and GMZ+OLA as therapeutic strategies. Viability, ra …
To determine the relevance of PARP1 in the development and treatment of PC, we used the Panc02 cell line to generate modified PC cells with …
Auditory cortical processing in cochlear-implanted children with different language outcomes.
Ibraheem OA, Kolkaila EA, Nada EH, Gad NH. Ibraheem OA, et al. Eur Arch Otorhinolaryngol. 2020 Jul;277(7):1875-1883. doi: 10.1007/s00405-020-05958-0. Epub 2020 Apr 8. Eur Arch Otorhinolaryngol. 2020. PMID: 32270327 Review.
METHODS: The study comprised 40 CI children who were divided into two groups according to their behavioral language evaluation outcomes: 20 good and 20 poor CI performers. They were age, gender, and socioeconomically matched. ...RESULTS: MMN existed in all good performers …
METHODS: The study comprised 40 CI children who were divided into two groups according to their behavioral language evaluation outcomes: 20 …
Olanzapine attenuates postoperative cognitive dysfunction in adult rats.
Tachi K, Fukuda T, Tanaka M. Tachi K, et al. Heliyon. 2021 Feb 12;7(2):e06218. doi: 10.1016/j.heliyon.2021.e06218. eCollection 2021 Feb. Heliyon. 2021. PMID: 33659744 Free PMC article.
The success rate in time of the OLA group was inferior to that of the CON group. On the other hand, the success rate in distance of the OLA group was similar to that of the CON group. Iba1 staining areas in the LPS and OLA groups were larger than that in the …
The success rate in time of the OLA group was inferior to that of the CON group. On the other hand, the success rate in distance of t …
114 results